Enzyme vs Synthetix — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Synthetix trades at Rp4,169 (market cap Rp1,43T, Rp236,09M 24h volume). The key difference: Synthetix is far larger — about 10661.3× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 344,5M SNX for Synthetix. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Synthetix for 67 Days on average.
| MLN | SNX | |
|---|---|---|
Market Cap | Rp134,13M | Rp1,43T |
Volume (24h) | Rp104,56M | Rp236,09M |
Circulating Supply | 3,3M MLN | 344,5M SNX |
Typical Hold Time | 28 Days | 67 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Synthetix (SNX) is trading at Rp4,171 with a market cap of Rp1.43T, showing a bullish technical signal supported by moving averages. The token is positioned above key support at Rp4,163, with neutral oscillators indicating balanced momentum. Recent ecosystem activity includes protocol upgrades enhancing synthetic asset trading, though no major fundamental shifts are reported. Trading volumes remain moderate, with on-chain metrics reflecting steady holder behavior.
Overall outlook is cautiously optimistic given technical strength, but risks include crypto market volatility and regulatory uncertainty. Key opportunities lie in network adoption growth, while investors should monitor liquidity and broader market sentiment. Major risks involve price swings and potential regulatory developments impacting DeFi protocols.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →SNX is a decentralized finance (DeFi) protocol that provides on-chain exposure to various crypto and non-crypto assets. The platform allows users to trade and exchange highly liquid synthetic assets (synths) autonomously.
Read more on SNX →